ESMO Immuno-Oncology 2023

6 - 8 December
Geneva, Switzerland

Poster presentation
Real-World Insights on Pan-Cancer Immune Checkpoint Inhibitor Treatment: Initial Findings of a Belgian Multicenter Study

📅 Date: 7 December
🕔 Time: 12.00 - 13.00
 👩‍⚕️ Presented by: Dr. Annelies T. Verbiest (University Hospital Antwerp (UZA), Belgium)

Dries Hens M.D. (Chief Medical Officer, co-founder), and Clara L. Oeste (Senior Medical Writer).
Set up a meeting with the LynxCare team through the calendar on the right. 👉

Unlock Insights in Immuno-Oncology
The comprehensive immuno-oncology datasets within LynxCare's European hospital network can offer you deep insights into patients treated with Immune Checkpoint Inhibitors.
Through timely, granular and Real-World Data for regulatory purposes, you can gain fresh perspectives on a.o. comorbidity factors, treatment patterns, adverse events (cardiotoxicity) and median overall survival. 

mail_dataset insights_onco_immuno onco_numbers-1

Unable to find a suitable timeslot or date?

Please inform us of your availability, and we'll schedule a meeting at your convenience.

More about LynxCare
Unlocking clinical insights from hospital care

LynxCare is a health tech company at the forefront of the healthcare data revolution. By harnessing the power of innovative technology (AI + NLP), we unlock all valuable data within hospitals (incl. narrative data gathered in medical records), build harmonized clinical databases, empowering hospitals and life sciences organizations to leverage real-world evidence for groundbreaking research and improving patient care.